Skip to main content
. 2022 Mar 20;146(1):42–50. doi: 10.1111/ane.13613

TABLE 3.

Rare heterozygous CNVs of interest identified in patients with VCI

Patient AAO Gender Type CNV Size (bp) Genes involved
236 64 M Gain chr6:163104432–165045334 1,940,903 PARK2, PACRG, LOC401282, CAHM, QKI
289 48 M Gain chr15:94876580–95356210 479,631 MCTP2
1005 60 F Gain chr7:19035920–20617266 1,581,347 HDAC9, TWIST1, FERD3L, TWISTNB, TMEM196, MACC1, ITGB8
1010 62 M Gain chr3:193061741–193467943 406,203 ATP13A5, ATP13A4, OPA1
1014 60 M Gain chr8:6155658‐6391302 a 235,645 ANGPT2, MCPH1, AGPAT5
chr8:6412551‐6574830 a 162,28
1029 63 F Loss chr16:15491006–16258173 767,168 MPV17L, BMERB1, MARF1, NDE1, MYH11, CEP20, ABCC1, ABCC6
1031 55 F Loss chr2:133949948–134070417 120,47 NCKAP5
1033 50 F Gain chr1:92293721–92574940 281,22 TGFBR3, BRDT, EPHX4, BTBD8
1039 27 M Loss chr12:43937166–44009983 72,818 ADAMTS20

Genome assembly: GRCh37/hg19.

Abbreviation: AAO, age at onset; bp, base pair.

a

The region between the two duplications in 8p23.1 was not covered in the GSAMD array.